BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29654065)

  • 1. Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.
    Sengupta S; Sobo M; Lee K; Senthil Kumar S; White AR; Mender I; Fuller C; Chow LML; Fouladi M; Shay JW; Drissi R
    Mol Cancer Ther; 2018 Jul; 17(7):1504-1514. PubMed ID: 29654065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2'-deoxyguanosine.
    Mender I; Gryaznov S; Dikmen ZG; Wright WE; Shay JW
    Cancer Discov; 2015 Jan; 5(1):82-95. PubMed ID: 25516420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma.
    Zhang G; Wu LW; Mender I; Barzily-Rokni M; Hammond MR; Ope O; Cheng C; Vasilopoulos T; Randell S; Sadek N; Beroard A; Xiao M; Tian T; Tan J; Saeed U; Sugarman E; Krepler C; Brafford P; Sproesser K; Murugan S; Somasundaram R; Garman B; Wubbenhorst B; Woo J; Yin X; Liu Q; Frederick DT; Miao B; Xu W; Karakousis GC; Xu X; Schuchter LM; Mitchell TC; Kwong LN; Amaravadi RK; Lu Y; Boland GM; Wei Z; Nathanson K; Herbig U; Mills GB; Flaherty KT; Herlyn M; Shay JW
    Clin Cancer Res; 2018 Oct; 24(19):4771-4784. PubMed ID: 29563139
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.
    Dorris K; Sobo M; Onar-Thomas A; Panditharatna E; Stevenson CB; Gardner SL; Dewire MD; Pierson CR; Olshefski R; Rempel SA; Goldman S; Miles L; Fouladi M; Drissi R
    J Neurooncol; 2014 Mar; 117(1):67-76. PubMed ID: 24477622
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Mender I; Batten K; Peyton M; Vemula A; Cornelius C; Girard L; Gao B; Minna JD; Shay JW
    Cancer Res; 2020 Mar; 80(5):929-936. PubMed ID: 31948943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere Stress Potentiates STING-Dependent Anti-tumor Immunity.
    Mender I; Zhang A; Ren Z; Han C; Deng Y; Siteni S; Li H; Zhu J; Vemula A; Shay JW; Fu YX
    Cancer Cell; 2020 Sep; 38(3):400-411.e6. PubMed ID: 32619407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel telomerase substrate precursor rapidly induces telomere dysfunction in telomerase positive cancer cells but not telomerase silent normal cells.
    Mender I; Gryaznov S; Shay JW
    Oncoscience; 2015; 2(8):693-5. PubMed ID: 26425659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.
    Carceller F; Fowkes LA; Khabra K; Moreno L; Saran F; Burford A; Mackay A; Jones DT; Hovestadt V; Marshall LV; Vaidya S; Mandeville H; Jerome N; Bridges LR; Laxton R; Al-Sarraj S; Pfister SM; Leach MO; Pearson AD; Jones C; Koh DM; Zacharoulis S
    J Neurooncol; 2016 Aug; 129(1):109-21. PubMed ID: 27180091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short and dysfunctional telomeres protect from allergen-induced airway inflammation.
    Piñeiro-Hermida S; Martínez P; Blasco MA
    Aging Cell; 2021 May; 20(5):e13352. PubMed ID: 33942458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in Gliomas.
    Yu S; Wei S; Savani M; Lin X; Du K; Mender I; Siteni S; Vasilopoulos T; Reitman ZJ; Ku Y; Wu D; Liu H; Tian M; Chen Y; Labrie M; Charbonneau CM; Sugarman E; Bowie M; Hariharan S; Waitkus M; Jiang W; McLendon RE; Pan E; Khasraw M; Walsh KM; Lu Y; Herlyn M; Mills G; Herbig U; Wei Z; Keir ST; Flaherty K; Liu L; Wu K; Shay JW; Abdullah K; Zhang G; Ashley DM
    Clin Cancer Res; 2021 Dec; 27(24):6800-6814. PubMed ID: 34593527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase-Mediated Strategy for Overcoming Non-Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance.
    Mender I; LaRanger R; Luitel K; Peyton M; Girard L; Lai TP; Batten K; Cornelius C; Dalvi MP; Ramirez M; Du W; Wu LF; Altschuler SJ; Brekken R; Martinez ED; Minna JD; Wright WE; Shay JW
    Neoplasia; 2018 Aug; 20(8):826-837. PubMed ID: 30015158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELK Inhibition in Diffuse Intrinsic Pontine Glioma.
    Meel MH; de Gooijer MC; Guillén Navarro M; Waranecki P; Breur M; Buil LCM; Wedekind LE; Twisk JWR; Koster J; Hashizume R; Raabe EH; Montero Carcaboso A; Bugiani M; van Tellingen O; van Vuurden DG; Kaspers GJL; Hulleman E
    Clin Cancer Res; 2018 Nov; 24(22):5645-5657. PubMed ID: 30061363
    [No Abstract]   [Full Text] [Related]  

  • 13. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models.
    Fischer-Mertens J; Otte F; Roderwieser A; Rosswog C; Kahlert Y; Werr L; Hellmann AM; Berding M; Chiu B; Bartenhagen C; Fischer M
    Cell Oncol (Dordr); 2022 Oct; 45(5):991-1003. PubMed ID: 35953764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma.
    Akamandisa MP; Nie K; Nahta R; Hambardzumyan D; Castellino RC
    Neuro Oncol; 2019 Jun; 21(6):786-799. PubMed ID: 30852603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models.
    Martínez-Vélez N; Garcia-Moure M; Marigil M; González-Huarriz M; Puigdelloses M; Gallego Pérez-Larraya J; Zalacaín M; Marrodán L; Varela-Guruceaga M; Laspidea V; Aristu JJ; Ramos LI; Tejada-Solís S; Díez-Valle R; Jones C; Mackay A; Martínez-Climent JA; García-Barchino MJ; Raabe E; Monje M; Becher OJ; Junier MP; El-Habr EA; Chneiweiss H; Aldave G; Jiang H; Fueyo J; Patiño-García A; Gomez-Manzano C; Alonso MM
    Nat Commun; 2019 May; 10(1):2235. PubMed ID: 31138805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide inhibits glioma cell growth through induction of telomerase displacement and telomere dysfunction.
    Cheng Y; Li Y; Ma C; Song Y; Xu H; Yu H; Xu S; Mu Q; Li H; Chen Y; Zhao G
    Oncotarget; 2016 Mar; 7(11):12682-92. PubMed ID: 26871293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models.
    Hennika T; Hu G; Olaciregui NG; Barton KL; Ehteda A; Chitranjan A; Chang C; Gifford AJ; Tsoli M; Ziegler DS; Carcaboso AM; Becher OJ
    PLoS One; 2017; 12(1):e0169485. PubMed ID: 28052119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein induces growth arrest and suppresses telomerase activity in brain tumor cells.
    Khaw AK; Yong JW; Kalthur G; Hande MP
    Genes Chromosomes Cancer; 2012 Oct; 51(10):961-74. PubMed ID: 22736505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
    Gits HC; Anderson M; Stallard S; Pratt D; Zon B; Howell C; Kumar-Sinha C; Vats P; Kasaian K; Polan D; Matuszak M; Spratt DE; Leonard M; Qin T; Zhao L; Leach J; Chaney B; Escorza NY; Hendershot J; Jones B; Fuller C; Leary S; Bartels U; Bouffet E; Yock TI; Robertson P; Mody R; Venneti S; Chinnaiyan AM; Fouladi M; Gottardo NG; Koschmann C
    Acta Neuropathol Commun; 2018 Jul; 6(1):67. PubMed ID: 30049282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.